Related Experiment Video

Updated: Mar 21, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.7K

Atrial Fibrillation and Stroke: Making Sense of Recent Observations on Anticoagulation

Marco Proietti1, Gregory Y H Lip2

  • 1Institute of Cardiovascular Sciences, University of Birmingham, City Hospital, Birmingham, UK; Department of Internal Medicine and Medical Specialties, Sapienza-University of Rome, Rome, Italy.

Cardiology Clinics
|May 7, 2016
PubMed

Insights

Atrial fibrillation (AF) patients face high mortality and stroke risks. Non-vitamin K antagonist oral anticoagulants (NOACs) offer effective and safer stroke prevention compared to warfarin.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Atrial fibrillation (AF) is the most common heart rhythm disorder, significantly increasing risks of all-cause mortality, cardiovascular mortality, and ischemic stroke.
  • Oral anticoagulation (OAC) therapy is crucial for stroke prevention in AF patients.
  • Vitamin K antagonists (VKAs) have been the standard OAC, but newer agents offer improved profiles.

Purpose of the Study:

  • To review current guidelines for stroke prevention in AF patients.
  • To summarize evidence on OACs, focusing on non-vitamin K antagonist oral anticoagulants (NOACs).
  • To analyze stroke prevention strategies across relevant patient subgroups and clinical features.

Main Methods:

  • Literature review of current guidelines and clinical evidence.
  • Synthesis of data on the efficacy and safety of OACs in AF.
  • Subgroup analysis based on patient characteristics and clinical presentation.

Main Results:

  • NOACs demonstrate comparable efficacy and improved safety over warfarin for stroke prevention in AF.
  • Evidence supports the use of NOACs across various patient subgroups.
  • Guidelines increasingly recommend NOACs for stroke risk management in AF.

Conclusions:

  • NOACs represent a significant advancement in stroke prevention for AF patients.
  • Current evidence supports tailored OAC selection based on patient profiles.
  • Optimizing OAC therapy is key to reducing AF-related morbidity and mortality.

Keywords:
Clinical characteristicsNon-vitamin K antagonist oral anticoagulantsOral anticoagulant therapyThromboembolic riskVitamin K antagonist

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.3K
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

2.2K

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
868
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
633
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.5K